Cargando…

A CRISPR-del-based pipeline for complete gene knockout in human diploid cells

The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Komori, Takuma, Hata, Shoji, Mabuchi, Akira, Genova, Mariya, Harada, Tomoki, Fukuyama, Masamitsu, Chinen, Takumi, Kitagawa, Daiju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038147/
https://www.ncbi.nlm.nih.gov/pubmed/36762651
http://dx.doi.org/10.1242/jcs.260000
_version_ 1784912022516793344
author Komori, Takuma
Hata, Shoji
Mabuchi, Akira
Genova, Mariya
Harada, Tomoki
Fukuyama, Masamitsu
Chinen, Takumi
Kitagawa, Daiju
author_facet Komori, Takuma
Hata, Shoji
Mabuchi, Akira
Genova, Mariya
Harada, Tomoki
Fukuyama, Masamitsu
Chinen, Takumi
Kitagawa, Daiju
author_sort Komori, Takuma
collection PubMed
description The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation of a premature stop codon. However, there is growing evidence that targeted genes are not always knocked out by the indel-based gene disruption. Here, we established a pipeline of CRISPR-del, which induces a large chromosomal deletion by cutting two different target sites, to perform ‘complete’ gene knockout efficiently in human diploid cells. Quantitative analyses show that the frequency of gene deletion with this approach is much higher than that of conventional CRISPR-del methods. The lengths of the deleted genomic regions demonstrated in this study are longer than those of 95% of the human protein-coding genes. Furthermore, the pipeline enabled the generation of a model cell line having a bi-allelic cancer-associated chromosomal deletion. Overall, these data lead us to propose that the CRISPR-del pipeline is an efficient and practical approach for producing ‘complete’ gene knockout cell lines in human diploid cells.
format Online
Article
Text
id pubmed-10038147
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Company of Biologists Ltd
record_format MEDLINE/PubMed
spelling pubmed-100381472023-03-25 A CRISPR-del-based pipeline for complete gene knockout in human diploid cells Komori, Takuma Hata, Shoji Mabuchi, Akira Genova, Mariya Harada, Tomoki Fukuyama, Masamitsu Chinen, Takumi Kitagawa, Daiju J Cell Sci Tools and Resources The advance of CRISPR/Cas9 technology has enabled us easily to generate gene knockout cell lines by introducing insertion–deletion mutations (indels) at the target site via the error-prone non-homologous end joining repair system. Frameshift-promoting indels can disrupt gene functions by generation of a premature stop codon. However, there is growing evidence that targeted genes are not always knocked out by the indel-based gene disruption. Here, we established a pipeline of CRISPR-del, which induces a large chromosomal deletion by cutting two different target sites, to perform ‘complete’ gene knockout efficiently in human diploid cells. Quantitative analyses show that the frequency of gene deletion with this approach is much higher than that of conventional CRISPR-del methods. The lengths of the deleted genomic regions demonstrated in this study are longer than those of 95% of the human protein-coding genes. Furthermore, the pipeline enabled the generation of a model cell line having a bi-allelic cancer-associated chromosomal deletion. Overall, these data lead us to propose that the CRISPR-del pipeline is an efficient and practical approach for producing ‘complete’ gene knockout cell lines in human diploid cells. The Company of Biologists Ltd 2023-03-07 /pmc/articles/PMC10038147/ /pubmed/36762651 http://dx.doi.org/10.1242/jcs.260000 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
spellingShingle Tools and Resources
Komori, Takuma
Hata, Shoji
Mabuchi, Akira
Genova, Mariya
Harada, Tomoki
Fukuyama, Masamitsu
Chinen, Takumi
Kitagawa, Daiju
A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title_full A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title_fullStr A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title_full_unstemmed A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title_short A CRISPR-del-based pipeline for complete gene knockout in human diploid cells
title_sort crispr-del-based pipeline for complete gene knockout in human diploid cells
topic Tools and Resources
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038147/
https://www.ncbi.nlm.nih.gov/pubmed/36762651
http://dx.doi.org/10.1242/jcs.260000
work_keys_str_mv AT komoritakuma acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT hatashoji acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT mabuchiakira acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT genovamariya acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT haradatomoki acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT fukuyamamasamitsu acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT chinentakumi acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT kitagawadaiju acrisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT komoritakuma crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT hatashoji crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT mabuchiakira crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT genovamariya crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT haradatomoki crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT fukuyamamasamitsu crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT chinentakumi crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells
AT kitagawadaiju crisprdelbasedpipelineforcompletegeneknockoutinhumandiploidcells